Dutch tech sector experiences a challenging quarter, with Mews securing the most investments among the top ten funding rounds.
In the first quarter of 2025, Dutch tech startups experienced a flourishing growth-stage funding environment, bucking the trend of global concerns that have impacted other regions.
While international investors have shown increasing caution, the Dutch venture capital market has demonstrated resilience and growth. Reports indicate a 67% increase in funding compared to Q2 2024, with approximately €747 million invested in Q2 2025[1]. The number of deals also increased from 79 in Q1 to 101 in Q2, marking one of the most active quarters in recent years for the Netherlands[1].
The strong investment growth and stable geopolitical conditions in the Netherlands have encouraged funds to deploy more capital, unlike the broader European context where total VC investment saw a slight decline from Q1 to Q2 2025[1].
Notable funding rounds include QuantWare, which raised €20 million for the design and manufacturing of superconducting quantum processors. In the biotech sector, Leyden Labs secured €63 million, Varmx raised €15 million, and Alesta Therapeutics bagged €65 million for their focus on rare diseases.
Moreover, the foodtech sector saw growth with Vivici, a Dutch startup producing animal-free dairy proteins, raising €32.5 million. Workwize, a provider of cloud-based software for managing IT hardware in remote and hybrid workplaces, secured €12 million. Mews, a hospitality software firm, raised €68 million ($75 million) in Q1 2025[2].
Despite global trade tensions and a sluggish exit market being areas of concern, the Dutch tech ecosystem remains optimistic. Techleap, a Dutch startup association, expressed confidence in the market, stating, "We can be proud of the Dutch entrepreneurs who, together with investors, realise world-class deep tech innovations"[1].
However, potential consequences of a hypothetical drop in growth-stage funding for Dutch tech startups could include slower scaling and development, reduced ability to attract top talent and innovation, and negative ripple effects on the broader ecosystem. Thankfully, current data indicates a stable or growing funding environment for Dutch tech startups in early 2025, which is likely to support continued innovation and ecosystem expansion[1][2].
In contrast to the premise, the Dutch tech startups have shown resilience and growth in the first quarter of 2025, boding well for the Dutch tech ecosystem rather than posing negative consequences[1][2].
References: [1] Techleap.nl. (2025). Q2 2025 Venture Capital Report. [Online] Available at: https://www.techleap.nl/wp-content/uploads/2025/07/Q2-2025-Venture-Capital-Report.pdf [2] StartupJuncture. (2025). Dutch Startup Funding in Q1 2025. [Online] Available at: https://www.startupjuncture.com/dutch-startup-funding-q1-2025/
QuantWare, Varmx, Leyden Labs, Vivici, Mews, Thorizon, Sirius Medical are mentioned but not explained in detail as they are not the main focus of the article.
- The Dutch venture capital market showcased a strong resilience and growth, contrasting the general-news of international investors' cautious approach, with technology-based startups experiencing a 67% increase in funding in Q2 2025 compared to Q2 2024.
- Amidst global concerns and a sluggish exit market, the technology sector in the Netherlands flourished, as demonstrated by the significant funding rounds raised by startups like QuantWare, Leyden Labs, and Vivici, thereby contributing to the general-news of a growing tech ecosystem.
